Tanya Arp Regnersgaard joined UNION in July 2021 as Project Director and was in April 2023 promoted to VP of Projects. Tanya brings more than 18 years of experience in the pharmaceutical and medical device industry.
Before joining UNION Tanya spent more than 11 years in LEO Pharma in various positions in both R&D and Commercial. She has extensive experience with portfolio and project management from early and late-stage development programs including life cycle management. The last three years, Tanya was the Global Launch Lead for tralokinumab, preparing for commercialization in US, EU & Japan of the novel monoclonal antibody to treat atopic dermatitis, which achieved EMA approval in June 2021 (Adtralza) and FDA approval in December 2021 (Adbry).
Tanya holds a Bachelor of Science in Export Engineering from the Engineering College of Copenhagen.
